Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Drug Resistance”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002213
What this trial is testing

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors

Who this might be right for
HIV Infections
Glaxo Wellcome 80
Not applicableUnknownNCT02306577
What this trial is testing

STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY)

Who this might be right for
HIVIllicit Drug User
Vancouver Infectious Diseases Centre 30
Large-scale testing (Phase 3)Study completedNCT03913195
What this trial is testing

Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection

Who this might be right for
HIV-1-infection
TaiMed Biologics Inc. 43
Not applicableUnknownNCT05312918
What this trial is testing

Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 603
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Not applicableStudy completedNCT00000785
What this trial is testing

A Registry of Tuberculosis Cases in the CPCRA

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 1,509
Not applicableEnrolling By InvitationNCT06706986
What this trial is testing

A Global Registry On Second gEneration and Long-acting inTegrase inhibiTor fAilures

Who this might be right for
HIVTherapy Failure
UMC Utrecht 250
Not applicableLooking for participantsNCT04098315
What this trial is testing

Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.

Who this might be right for
HIV-1-infectionMulti-Antiviral Resistance
Castagna Antonella 300
Post-approval studies (Phase 4)Study completedNCT00372632
What this trial is testing

IPT of Malaria With SP in Different Zones of Drug Resistance in Rwanda

Who this might be right for
Non HIV Infected Pregnant Women
Institute of Tropical Medicine, Belgium 1,717
Testing effectiveness (Phase 2)UnknownNCT04560569
What this trial is testing

Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection

Who this might be right for
HIV/AIDS
Frontier Biotechnologies Inc. 20
Not applicableStudy completedNCT00581802
What this trial is testing

HIV Resistance and Treatment Strategies

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 89
Large-scale testing (Phase 3)Looking for participantsNCT06747507
What this trial is testing

Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance

Who this might be right for
HIV-1-infection
University of Nairobi 392
Testing effectiveness (Phase 2)Study completedNCT00204308
What this trial is testing

Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP

Who this might be right for
HIVPregnancy
University of North Carolina, Chapel Hill 400
Not applicableUnknownNCT05514418
What this trial is testing

Effectiveness of Intensive Adherence Counselling Among People Living With HIV/AIDS With Low-level Viraemia in Uganda.

Who this might be right for
HIV/AIDS
Makerere University 136
Not applicableStudy completedNCT00000947
What this trial is testing

Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 850
Not applicableStudy completedNCT04233242
What this trial is testing

Genotype-Informed Versus Empiric Management of VirEmia

Who this might be right for
HIV-1-infection
Swiss Tropical & Public Health Institute 286
Testing effectiveness (Phase 2)Study completedNCT00027339
What this trial is testing

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 53
Not applicableStudy completedNCT04050449
What this trial is testing

Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD

Who this might be right for
HIV-1-infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 1,339
Large-scale testing (Phase 3)Study completedNCT00054717
What this trial is testing

Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)

Who this might be right for
HIV Infections
Boehringer Ingelheim 630
Not applicableWithdrawnNCT03928834
What this trial is testing

Sustainable Adherence and Prevention of HIV Drug Resistance in Adolescents

Who this might be right for
Medication AdherenceHIV Drug Resistance
University of Zimbabwe
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation